Abstract
Purpose
To report a novel mutation of ALMS1 in a Chinese family with Alström syndrome.
Design
Observational case report and results of DNA analysis.
Methods
A family including one patient and four unaffected relatives was examined clinically. One hundred normal Chinese individuals served as control subjects. Genomic DNA was extracted from venous blood of all participants. Exons 8, 10, and 16 of the ALMS1 gene was amplified by the PCR. The PCR products were analysed using direct sequencing.
Results
Clinical examination and laboratory investigations indicate Alström syndrome for the proband of this family. Sequencing of part of the ALMS1 gene identified one novel homozygous non-sense mutation, c.8335 C>T, resulting in a premature termination signal at codon 2471 (Q2471X).
Conclusions
Our findings expand the spectrum of ALMS1 gene mutations causing Alström syndrome and further confirm the role of ALMS1 gene in the pathogenesis of Alström syndrome.
Similar content being viewed by others
Introduction
Alström syndrome is a rare and severe autosomal recessive disorder. Alström initially identified five clinical features of this syndrome, such as atypical retinal pigmentary degeneration, sensorineural hearing loss, obesity, type II diabetes mellitus, and normal mentation.1, 2 The disease-causing gene for it was the ALMS1 gene. The previous works reported 21 ALMS1 mutations that caused premature protein truncation.3, 4, 5
Methods and results
Case report
A 9-year-old boy from a Chinese third-generation family (Figure 1a) presented with poor vision (20/200 OU), photophobia, nystagmus, and blepharospasm (Figure 2a). Fundus examination showed pale optic discs and narrowed vessels. No pigment spicules were observed. Bilateral sensorineural hearing loss was observed in the proband by audiometry. General physical examination showed that the boy was of short stature and obese (weight 48 kg and height 126 cm). He presented acanthosis nigricans in the neck and axillae (Figure 2b). The testicles and phallus were small. Laboratory investigations indicated that the complete blood count was normal; levels of creatinine, total bilirubin, and conjugated bilirubin were in the normal range. Levels of aspartate aminotransferase (AST, SGOT, 145 U/I; range, 5–40), alanine aminotransferase (ALT, SGPT, 286 U/I; range, 5–40), glucose (9.55 mmol/l; range, 3.9–5.8), and blood urea nitrogen (7.96 mmol/l; range, 2.50–6.30) were elevated; microscopic examination of the urine showed that the levels of glucose (14 mmol; range, 0.72–2.78) and protein (0.3 g/l; range, 0.02–0.06) were elevated.
By direct sequencing of the exons 8, 10, and 16 of ALMS1 gene, we identified a novel homozygous non-sense mutation in exon 10, c.8335 C>T (Q2471X) in the boy (Figure 1c and d). The boy's parents and his younger sister carried the heterozygous Q2471X change, consistent with carrier status (Figure 1b). The mutation was absent in 100 normal controls.
Comment
Alström syndrome bears some clinical features with other syndromes such as Laurence–Moon syndrome, Edwards disease, and Bardet–Biedl syndrome.1, 2 The diagnosis of it is often difficult. The ALMS1 gene mutation screen may play an important role for the diagnosis.
Here, we reported an identification of one novel mutation in a Chinese family with Alström syndrome. Our finding expands the spectrum of the ALSM1 gene mutations in Alström syndrome and provides the genetic counselling for the family.
References
Alström CH, Hallgren B, Nilsson LB . Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness. A specific syndrome (not hitherto described) distinct from the Laurence–Moon–Bardet–Biedl syndrome. Acta Psychatr Neurol Scand 1959; 34 (Suppl 129): 1.
Russell-Eggitt I, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF . Alström syndrome. Report of 22 cases and literature review. Ophthalmology 1998; 105: 1274–1280.
Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 2002; 31 (1): 74–78.
Bond J, Flintoff K, Higgins J, Scott S, Bennet C, Parsons J et al. The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet 2005; 42 (2): e10.
Minton JA, Owen KR, Ricketts CJ, Crabtree N, Shaikh G, Ehtisham S et al. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alström syndrome. J Clin Endocrinol Metab 2006; 91 (8): 3110–3116.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, L., Dong, B., Chen, X. et al. Identification of a novel ALMS1 mutation in a Chinese family with Alström syndrome. Eye 23, 1210–1212 (2009). https://doi.org/10.1038/eye.2008.235
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2008.235